Mark Majoch, MD
Family Medicine · Duluth, GANPI 1306811823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $649 and has fallen 65.2% since, to $226 in 2025.
Across 168 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$414
- Novo Nordisk$351
- AbbVie$335
- Amarin Pharma, Inc.$177
- IBSA Pharma Inc.$173
- Amgen$159
- plus $897 from 21 others
What the payments were for
- Food & beverage$2,45298%
- Education$542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 37 | $414 |
| Novo Nordisk | 26 | $351 |
| AbbVie(2 entities) | 26 | $335 |
| Amarin Pharma, Inc. | 8 | $177 |
| IBSA Pharma Inc. | 11 | $173 |
| Amgen(2 entities) | 8 | $159 |
| AstraZeneca | 6 | $107 |
| Lilly USA, LLC | 6 | $96 |
| Eisai Inc. | 6 | $73 |
| Boston Scientific | 2 | $66 |
| Arbor Pharmaceuticals, Inc. | 4 | $65 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
| Genentech USA, Inc. | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Abbott | 2 | $37 |
| Boehringer Ingelheim | 2 | $37 |
| Mylan Specialty L.p. | 2 | $36 |
| Novartis | 2 | $33 |
| Exact Sciences | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Medicure Pharma Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $11 |
How this compares
$2,506 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $29,332 |
| XareltoRivaroxaban | 18 | $22,340 |
| OzempicSemaglutide | 22 | $20,881 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $14,453 |
| EliquisApixaban | 12 | $13,030 |
| BelsomraSuvorexant | 11 | $4,651 |
| PaxlovidNirmatrelvir/Ritonavir | 17 | $4,134 |
| Oxycodone Hcl | 105 | $2,784 |
| Levothyroxine Sodium | 202 | $2,510 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 79 | $2,430 |
| Rosuvastatin Calcium | 263 | $2,228 |
| Pantoprazole Sodium | 191 | $2,210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $1,850 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 78 | $1,804 |
| Atorvastatin Calcium | 246 | $1,781 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $414 | $29,33232 claims |
| Novo NordiskOzempic | $351 | $20,88122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Duluth
- Woun SeokDuluth$26K
- Sool SongDuluth$23K
- Jina KimDuluth$21K
- Rohit DesaiDuluth$20K
- Young Tae KimDuluth$19K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.